e-Drug3D 384 |
FLAVOXATE
|
cas 15301-69-6 |
CLASS GENITO |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 1.86 HOUR |
Target - PDB Ligand code = HWL (link to the list of PDB complexes) Download experimental 3D coordinates of HWL with added hydrogens |
DrugCentral Phosphodiesterase 4 UNIPROT P27815 PDE4A Phosphodiesterase 7 UNIPROT Q13946 PDE7A |
Download SDF file | 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate Formula: Calculated chemical properties: MW 391.45 NB_atoms 29 XLogP 4.41 PSA 54.261 NB_HD 0 NB_HA 5 fsp3 0.33 Lipinski(0=no;1=yes) 1 |
FDA NDA 016769 (pdf not found) INN (FLAVOXATE HYDROCHLORIDE) URISPAS (ORTHO MCNEIL JANSSEN) APPROVAL= AP YEAR= 1970 DISCONTINUED NDA 076234 (pdf not found) INN (FLAVOXATE HYDROCHLORIDE) FLAVOXATE HYDROCHLORIDE (IMPAX PHARMS) APPROVAL= AP YEAR= 2003 DISCONTINUED NDA 076831 (pdf not found) INN (FLAVOXATE HYDROCHLORIDE) FLAVOXATE HYDROCHLORIDE (PADAGIS US) APPROVAL= AP YEAR= 2004 NDA 076835 (pdf not found) INN (FLAVOXATE HYDROCHLORIDE) FLAVOXATE HYDROCHLORIDE (EPIC PHARMA) APPROVAL= AP YEAR= 2005 |
Other links: |